About Aurex Laboratories
Aurex Laboratories is a company based in Windsor (Canada) founded in 2014 was acquired by Apnar Pharma in February 2022. Aurex Laboratories offers products and services including DEPO288 Platform and Promotions Service.
- Headquarter Windsor, Canada
-
Sectors
Healthcare
-
Email
Locked
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Aurex Laboratories Private Limited
- Date of Incorporation 11 Aug, 2015
- Jurisdiction Hyderabad, Telangana, India
-
Annual Revenue
$166.95 K (USD)181.91as on Mar 31, 2023
-
Net Profit
-$80.05 K (USD)10.7as on Mar 31, 2023
-
EBITDA
-$75.88 K (USD)-12.21as on Mar 31, 2023
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Acquired by
Apnar Pharma
(Feb 07, 2022)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Aurex Laboratories
Aurex Laboratories offers a comprehensive portfolio of products and services, including DEPO288 Platform and Promotions Service.
Platform for accessing online games with secure login.
Offers vouchers and discounts for gaming activities.
Funding Insights of Aurex Laboratories
Detailed funding history for Aurex Laboratories
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in Aurex Laboratories
Aurex Laboratories has secured backing from 1 investor. Prominent investors backing the company include Apnar Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Produces high-quality pharmaceutical products including tablets, capsules, syrups, and injectables.
|
Locked | Locked | Locked |
Investor details for Aurex Laboratories
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Aurex Laboratories
Investment portfolio details for Aurex Laboratories
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
Financial Statements - Aurex Laboratories
Detailed financials for Aurex Laboratories
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Aurex Laboratories Comparisons
Peer comparison for Aurex Laboratories
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of Aurex Laboratories
Detailed competitors of Aurex Laboratories
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Aurex Laboratories
Complete news archive for Aurex Laboratories
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Aurex Laboratories
Aurex Laboratories was founded in 2014.
Aurex Laboratories is headquartered in Windsor, Canada. It is registered at Windsor, Ontario, Canada.
Ranga Aravapalli is the current CEO of Aurex Laboratories.
Annual revenue of Aurex Laboratories is $166.95K as on Mar 31, 2023.
Aurex Laboratories was established in 2014 in Windsor, Canada, within the pharmaceutical sector. Research and development efforts are directed toward the manufacturing of drugs across various therapeutic areas. Operations encompass the production of pharmaceutical products to support diverse medical needs. Leadership is provided by Ranga Aravapalli, serving as CEO. The companys domain, aurexlabs.com, facilitates its activities in this field.
Aurex Laboratories offers DEPO288 Platform and Promotions Service.
Aurex Laboratories has 1 investor. Key investors include Apnar Pharma.